Search Results for transfemoral carotid artery stenting
New data underscore physician experience levels required to derive benefit from transfemoral carotid artery stenting

Data from a new study that maps out the levels at which adverse postoperative events decrease following transfemoral carotid artery stenting (TfCAS) based on depth of physician experience with the procedure represent an “absolute minimum threshold of learning,” the lead…
TCAR has ‘tremendous appeal’ as alternative to transfemoral carotid artery stenting

This video is sponsored by Silk Road Medical. Richard Powell, MD, from Lebanon, New Hampshire, talks to Vascular Specialist at the Society for Vascular Surgery’s Vascular Annual Meeting (SVS VAM; June 15–18) in Boston about his initial interest in the transcarotid…
Carotid endarterectomy shows ‘improved long-term durability’ over transfemoral carotid artery stenting

An increased postoperative stroke rate associated with transfemoral carotid artery stenting “seems to extend up to five years’ follow-up” compared to carotid endarterectomy. This is the conclusion set to be presented by Kevin S. Yei, BS, of the University of…
TCAR outperforms transfemoral carotid artery stenting, ‘significantly’ lowering stroke and death risk

A study that set out to determine whether there was a lesser stroke or death risk by deploying transcarotid artery revascularization (TCAR) over the transfemoral approach among patients receiving treatment for carotid stenosis suggested a statistically significant advantage for the…
Transcarotid vs. Transfemoral Carotid Artery Stenting in the SVS Vascular Quality Initiative

The Safety and Efficacy Study for Reverse Flow Used during Carotid Artery Stenting Procedure (ROADSTER) multicenter trial reported the lowest stroke rate in high-risk patients compared with any prospective trial of TFCAS, according to Mahmoud B. Malas, MD, of the…
ROADSTER 3 analysis explores role of TCAR in asymptomatic carotid disease

The CREST-2 trial provided important new evidence on carotid revascularization in asymptomatic patients, but it left one question unanswered: Where does transcarotid artery revascularization (TCAR) fit? A new analysis from the ROADSTER 3 trial offers a direct look at that…
Carotid endarterectomy tied to lower stroke, mortality rates than stenting

Carotid endarterectomy (CEA) was associated with significantly lower long-term stroke and mortality compared to carotid artery stenting (CAS) in patients with asymptomatic carotid artery disease, according to a new real-world analysis. The study, which was presented at VAM 2026, compared…
Not all carotid procedures are equal after patients suffer a postoperative stroke

Comparative analysis looks at stroke-related disability and mortality after three modes of carotid revascularization. Strokes after transfemoral carotid artery stenting (TFCAS) were “the most disabling and lethal” when compared with transcarotid artery revascularization (TCAR) and carotid endarterectomy (CEA) in a…
Drilling into controversies in field of asymptomatic severe carotid stenosis management

Some of the enduring controversies in the management of asymptomatic severe carotid stenosis will underpin an educational session set to take place today. The session tackles debate around the deployment of carotid revascularization strategies in both standard- and high-risk patient…
Debate verdict: Carotid endarterectomy maintains its golden hue

The established “gold-standard” approach to carotid revascularization remained enshrined as the go-to operation as far as a 2025 Charing Cross (CX) International Symposium audience was concerned. Some 76% of those who voted in the post-debate poll sided with Barbara Rantner,…

